Effects of L-DOPA on the physiological nocturnal sleep of patients with facial paraspasm
Di Perri, R.; Di Rosa, A.E.; Leggiadro, N.; Meduri, M.
Acta Neurologica 29(6): 675-680
1974
ISSN/ISBN: 0001-6276 PMID: 4470322 Document Number: 73874
Document emailed within 1 workday
Related Documents
Bergonzi, P.; Chiurulla, C.; Gambi, D.; Mennuni, G.; Pinto, F. 1975: L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment Acta Neurologica Belgica 75(1): 5-10Puca, F.M.; Bricolo, A.; Turella, G. 1972: Effects of L-dopa or amantadine treatment on the spindles of sleep in Parkinson's syndromes Revue Neurologique (Paris) 127(2): 313
Geissbuhler, F.; Eisenring, J.J.; Friedli, P.; Bartholini, G.; Tissot, R. 1972: Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects L'Encephale 61(2): 127-148
Richardt, D.; Driver, H.S. 1996: An evaluative study of the short-term effects of once-daily, sustained-release theophylline on sleep in nocturnal asthmatics South African Medical Journal 86(7): 803-804
Vergara, J.M.; Brualla, J.; Serrano, M.; Arcocha, J.; López, J. 1999: Subjective sleep quality and spectral analysis of electroencephalography during nocturnal sleep Revista de Neurologia 28(8): 765-767
Shibagaki, M.; Kiyono, S.; Matsuno, Y. 1985: Nocturnal sleep of severely mentally retarded children and adolescents: ontogeny of sleep patterns American Journal of Mental Deficiency 90(2): 212-216
Juvancz, P. 1981: The sleep of artificially reared newborn rats, effect of alpha-methyl-DOPA treatment on paradoxical sleep and on adult behaviour Acta Physiologica Academiae Scientiarum Hungaricae 57(1): 87-98
Lin, C.C.; Huang, W.C. 1992: Sleep quality and nocturnal hypoxemia in patients with chronic obstructive pulmonary disease Journal of the Formosan Medical Association 91(Suppl): S232-S238
Wang, R.M. 1994: Nursing observation of arrhythmia in patients with coronary atherosclerotic heart disease during nocturnal sleep Zhonghua Hu Li Za Zhi 29(12): 729-731
Bergonzi, P.; Chiurulla, C.; Tempesta, E. 1971: Organization of nocturnal sleep in parkinsonian patients: modifications of the phases and cycles in the course of pharmacological treatment Rivista di Neurologia 41(5): 326-334
Xiao, Y.; Zhong, X.; Huang, R.; Sun, G.-Q. 2007: The evaluation of the severity of nocturnal oxygen desaturation of patients with obstructive sleep apnea hypopnea syndrome Zhonghua Nei Ke Za Zhi 46(6): 458-461
Gao, X.-y.; Ma, Q.-l.; Hu, B. 2007: Effects of acupuncture at "Sishencong" (EX-HN 1) on physiological functions in the sleep disorder model mouse Zhongguo Zhen Jiu 27(9): 681-683
Hindmarch, I.; Parrott, A.C. 1980: The effects of combined sedative and anxiolytic preparations on subjective aspects of sleep and objective measures of arousal and performance the morning following nocturnal medication. I: Acute doses Arzneimittel-Forschung 30(6): 1025-1028
Riess, M.; Koehler, U.; Gueldenring, D.; Fett, I.; Naumann-Koch, C.; Peter, J.H.; Ploch, T.; Stellwaag, M.; Blanke, H.; von Wichert, P. 1989: Results of left heart catheterization study in 64 patients with nocturnal disorders of respiratory control (sleep apnea) Pneumologie 43(Suppl 1): 611-615
Muenter, M.D.; Tyce, G.M. 1971: L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects Mayo Clinic Proceedings 46(4): 231-239
Vasil'ev, V.N. 1980: Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients Voprosy Meditsinskoi Khimii 26(6): 782-786
Routh, J.I.; Bannow, R.E.; Fincham, R.W.; Stoll, J.L. 1971: Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy Clinical Chemistry 17(9): 867-871
Lombardo, L. 1973: Efficacy and side effects of L-dopa in patients with Parkinson's syndrome Archivos de Investigacion Medica 4(3): 215-224
Indo, T.; Takahashi, A. 1987: Should L-dopa therapy for Parkinson's disease be started early or late? Clinical course of the major tetrad in 122 Parkinsonian patients treated with L-dopa over 14 years Rinsho Shinkeigaku 27(11): 1419-1422
Castaldo, V.; Krynicki, V.E.; Crade, M. 1973: L-dopa and REM sleep in normal and mentally retarded subjects Biological Psychiatry 6(3): 295-299